Demiana Faltaos

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy

S. Urien, J. Hulot, V. Leblond, 2006, Cancer Chemotherapy and Pharmacology.

Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265, in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET).

P. Jänne, J. Nemunaitis, J. Christensen, 2016 .